» Articles » PMID: 37127825

Delayed Puberty

Overview
Specialty Pediatrics
Date 2023 May 1
PMID 37127825
Authors
Affiliations
Soon will be listed here.
Abstract

Testicular volume ≥4 ml and appearance of breast budding are the first signs of puberty. Delayed puberty is diagnosed in the absence of thelarche by 13 y or menarche by 15 y in girls and absence of testicular enlargement by 14 y in boys. Delayed puberty can be due to hypogonadotrophic hypogonadism, hypergonadotrophic hypogonadism or eugonadotrophic eugonadism characterised by low, elevated and normal gonadotrophin levels, respectively. Constitutional Delay of Growth and Puberty (CDGP) and systemic illness should be considered before pathological causes. Assessment of sexual maturity by Tanner's staging and anthropometric assessment on growth chart is pivotal. Lack of menarche in girls with thelarche suggests structural abnormalities of reproductive tract or disorders of sexual development. Measurement of bone age helps to interpret hormone measurements and decide on timing of pubertal induction. Ultrasound assessment of abdomen gives valuable clues to pubertal onset (in girls) and possible underlying etiology. Karyotyping is mandatory in all girls with delayed puberty and short stature, and delayed menarche and boys with hypergonadotrophic hypogonadism. Gonadotrophin releasing hormone analogue stimulation test may help distinguish hypogonadotrophic hypogonadism from CDGP. Pubertal induction is done with intramuscular testosterone and oral estradiol in boys and girls, respectively. Hormone replacement is begun at low doses and slowly escalated over 2 y to mimic a physiological puberty process. Short course of testosterone for 3 to 6 mo is helpful in adolescent boys with CDGP and psychological distress. Attainment of adult sexual maturity by 18 y is mandatory to rule out disorders of hypothalamic pituitary gonadal axis.

Citing Articles

Pubertal induction therapy in pediatric patients with Duchenne muscular dystrophy.

Sodero G, Cipolla C, Rigante D, Arzilli F, Mercuri E J Pediatr Endocrinol Metab. 2025; .

PMID: 40068954 DOI: 10.1515/jpem-2025-0061.


From biological marker to clinical application: the role of anti-Müllerian hormone for delayed puberty and idiopathic non-obstructive azoospermia in males.

Zeng Y, Yuanyuan Z, Guicheng Z, Zhao G, Yi Z, Zheng Y Endocr Connect. 2025; 14(3).

PMID: 39804180 PMC: 11799830. DOI: 10.1530/EC-24-0630.


The estimation of pubertal growth spurt parameters using the superimposition by translation and rotation model in Korean children and adolescents: a longitudinal cohort study.

Chun D, Kim S, Kim Y, Suh J, Kim J Front Pediatr. 2024; 12:1372013.

PMID: 39376676 PMC: 11457228. DOI: 10.3389/fped.2024.1372013.


A Current Perspective on Delayed Puberty and Its Management.

Abaci A, Besci O J Clin Res Pediatr Endocrinol. 2024; 16(4):379-400.

PMID: 38683021 PMC: 11629716. DOI: 10.4274/jcrpe.galenos.2024.2024-2-7.


Pediatric Endocrinology in Office Practice - The Way Forward.

Prasad H, Bajpai A Indian J Pediatr. 2023; 90(6):572-573.

PMID: 37140837 DOI: 10.1007/s12098-023-04618-5.

References
1.
Rey R . Recent advancement in the treatment of boys and adolescents with hypogonadism. Ther Adv Endocrinol Metab. 2022; 13:20420188211065660. PMC: 8753232. DOI: 10.1177/20420188211065660. View

2.
Fenichel P . Delayed puberty. Endocr Dev. 2012; 22:138-159. DOI: 10.1159/000326686. View

3.
Martin D, Wit J, Hochberg Z, Savendahl L, van Rijn R, Fricke O . The use of bone age in clinical practice - part 1. Horm Res Paediatr. 2011; 76(1):1-9. DOI: 10.1159/000329372. View

4.
Marshall W, Tanner J . Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969; 44(235):291-303. PMC: 2020314. DOI: 10.1136/adc.44.235.291. View

5.
Marshall W, Tanner J . Growth and physiological development during adolescence. Annu Rev Med. 1968; 19:283-300. DOI: 10.1146/annurev.me.19.020168.001435. View